Present status and future direction of clinical trials in advanced endometrial carcinoma

by Homesley, Howard D.
Published 2008

Endometrial carcinoma in vitro chemosensitivity testing of single and combination chemotherapy regimens using the novel microculture kinetic apoptosis assay: implications for endom...

by Ballard, Karen S., Homesley, Howard D., Hodson, Charles, Presant, Cary A., Rutledge, James, Hallquist, Allan, Perree, Mathieu
Published 2010

Fixed-dose rate gemcitabine plus docetaxel as second-line therapy for metastatic uterine leiomyosarcoma: a Gynecologic Oncology Group phase II study

by Hensley, Martee L., Blessing, John A., DeGeest, Koen, Abulafia, Ovadia, Rose, Peter G., Homesley, Howard D.
Published 2008

The addition of paclitaxel to doxorubicin and cisplatin and volume-directed radiation does not improve overall survival (OS) or long-term recurrence-free survival (RFS) in advanced...

by Spirtos, Nick M., Enserro, Danielle, Homesley, Howard D., Gibbons, Susan K., Cella, David, Morris, Robert T., DeGeest, Koen, Lee, Roger B., Miller, David S.
Published in Gynecol Oncol (2019)

A phase II study of paclitaxel for the treatment of ovarian stromal tumors: An NRG Oncology/ Gynecologic Oncology Group Study()

by Burton, Elizabeth R., Brady, Mark, Homesley, Howard D., Rose, Peter G., Nakamura, Toshiaki, Kesterson, Joshua P., Rotmensch, Jacob, Thigpen, J. Tate, Van Le, Linda
Published in Gynecol Oncol (2015)

A Randomized Phase III Trial in Advanced Endometrial Carcinoma of Surgery and Volume Directed Radiation Followed by Cisplatin and Doxorubicin with or without Paclitaxel: A Gynecolo...

by Homesley, Howard D., Filiaci, Virginia, Gibbons, Susan K., Long, Harry J., Cella, David, Spirtos, Nick M., Morris, Robert T., DeGeest, Koen, Lee, Roger, Montag, Anthony
Published in Gynecol Oncol (2008)

Patient Reported Outcomes of a Randomized, Placebo-Controlled Trial of Bevacizumab in the Front-Line Treatment of Ovarian Cancer: A Gynecologic Oncology Group Study

by Monk, Bradley J., Huang, Helen Q., Burger, Robert A., Mannel, Robert S., Homesley, Howard D., Fowler, Jeffrey, Greer, Benjamin E., Boente, Matthew, Liang, Sharon X., Wenzel, Lari
Published 2012

Ascites predicts treatment benefit of bevacizumab in front-line therapy of advanced epithelial ovarian, fallopian tube and peritoneal cancers: An NRG Oncology/GOG study

by Ferriss, James S, Java, James J, Bookman, Michael A, Fleming, Gini F, Monk, Bradley J, Walker, Joan L, Homesley, Howard D, Fowler, Jeffrey, Greer, Benjamin E, Boente, Matthew P, Burger, Robert A
Published in Gynecol Oncol (2015)

Risk Factors for GI Adverse Events in a Phase III Randomized Trial of Bevacizumab in First-Line Therapy of Advanced Ovarian Cancer: A Gynecologic Oncology Group Study

by Burger, Robert A., Brady, Mark F., Bookman, Michael A., Monk, Bradley J., Walker, Joan L., Homesley, Howard D., Fowler, Jeffrey, Greer, Benjamin E., Boente, Matthew, Fleming, Gini F., Lim, Peter C., Rubin, Stephen C., Katsumata, Noriyuki, Liang, Sharon X.
Published 2014

Final Overall Survival of a Randomized Trial of Bevacizumab for Primary Treatment of Ovarian Cancer

by Tewari, Krishnansu S., Burger, Robert A., Enserro, Danielle, Norquist, Barbara M., Swisher, Elizabeth M., Brady, Mark F., Bookman, Michael A., Fleming, Gini F., Huang, Helen, Homesley, Howard D., Fowler, Jeffrey M., Greer, Benjamin E., Boente, Matthew, Liang, Sharon X., Ye, Chenglin, Bais, Carlos, Randall, Leslie M., Chan, John K., Ferriss, J. Stuart, Coleman, Robert L., Aghajanian, Carol, Herzog, Thomas J., DiSaia, Philip J., Copeland, Larry J., Mannel, Robert S., Birrer, Michael J., Monk, Bradley J.
Published in J Clin Oncol (2019)